Neo Performance Materials (NEO) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 May, 2026Executive summary
Achieved record Q1 2026 results with revenue of $155 million and Adjusted EBITDA of $36.2 million, up 111% year-over-year, marking the highest in company history.
All business segments—Magnequench, Chemicals & Oxides, and Rare Metals—contributed to growth, with Rare Metals delivering significant earnings gains.
Operational momentum and strategic progress included the production of the one-millionth magnet at the European facility and commissioning of a heavy rare earth separation line in Estonia.
Entered a multi-year AI research partnership with Tallinn University of Technology to embed AI in operations and enhance manufacturing.
Raised full-year 2026 Adjusted EBITDA guidance to $100–$110 million, up from $75–$80 million.
Financial highlights
Q1 2026 revenue was $155 million, a 27% increase year-over-year.
Adjusted EBITDA reached $36.2 million (23.4% margin), more than doubling from $17.1 million (14.1% margin) in Q1 2025.
Adjusted EPS was $0.36 for the quarter; Adjusted Net Income was $14.9 million.
Ended the quarter with $41.7 million in cash and $154 million in total debt.
Operating income rose to $26.6 million from $9.6 million year-over-year.
Outlook and guidance
Increased 2026 Adjusted EBITDA guidance to $100–$110 million, reflecting strong Q1 and favorable pricing.
Management anticipates continued growth driven by global supply chain localization, electrification, automation, and aerospace trends.
Inventory normalization expected to drive positive free cash flow through the rest of the year.
Latest events from Neo Performance Materials
- Record financial results and European expansion highlight leadership in rare earth magnetics.NEO
Investor presentation12 May 2026 - Strong 2025 results and European expansion position Neo as a leader in rare earth magnetics.NEO
Investor presentation25 Mar 2026 - 2025 Adjusted EBITDA up 17% to $75.6M, exceeding guidance; 2026 outlook remains strong.NEO
Q4 202519 Mar 2026 - Q3 2025 revenue up 9.8% to $122.2M, Adjusted EBITDA $19.2M, and guidance raised.NEO
Q3 20253 Feb 2026 - 2024 Adjusted EBITDA guidance raised to $45–$50M amid margin gains and strategic progress.NEO
Q2 20241 Feb 2026 - Q2 2025 Adjusted EBITDA up 42% to $19M; guidance raised to $64M–$68M on strong segment growth.NEO
Q2 202529 Jan 2026 - Q1 2025 Adjusted EBITDA up 60% year over year, with strong growth and robust liquidity maintained.NEO
Q1 202529 Jan 2026 - Q3 2024 Adjusted EBITDA up 50% year-over-year; outlook raised amid strategic divestitures.NEO
Q3 202429 Jan 2026 - Adjusted EBITDA up 70%+ to $64.4M, with strong Rare Metals and Magnequench growth.NEO
Q4 202419 Dec 2025